REGENXBIO Inc.RGNXNASDAQ
Loading
RGNX Revenue Growth (YoY Quarterly)•+43.00%
Stock Alarm Pro
Growth Metrics
Latest: Q4 2025vs Q3 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
+43.00%
+20.1pp
+63.86%
+435.6pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+1.73%
-0.0pp
+1.73%
-0.0pp
+0.00%
+0.0pp
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -4.50% | +469.79% | -4.20% | +22.88% | +43.00% |
| Gross Profit Growth | +124.34% | +1095.36% | +59.75% | -371.74% | +63.86% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +15.61% | +12.31% | +1.74% | +1.75% | +1.73% |
| Weighted Average Shares Diluted Growth | +15.61% | +12.47% | +1.74% | +1.75% | +1.73% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -18.12% | +10.57% | -11.20% | +5.10% | +22.31% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -18.81% | -21.98% | +2.05% | +1.17% | -2.78% |
| Book Value per Share Growth | -27.96% | -37.51% | -39.70% | -47.36% | -61.11% |
| Debt Growth | -8.13% | -53.19% | -51.05% | +218.98% | +217.58% |
| R&D Expense Growth | -1.88% | +4.78% | +24.05% | +3.07% | +18.32% |
| SG&A Expenses Growth | +5.09% | +11.24% | +5.45% | +4.28% | +11.62% |
1 / 4